- Home
- DAWN vs ULH Comparison
DAWN vs ULH Comparison
Compare DAWN & ULH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- ULH
- Stock Information
- Founded
- DAWN 2018
- ULH 1932
- Country
- DAWN United States
- ULH United States
- Employees
- DAWN N/A
- ULH N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- ULH Trucking Freight/Courier Services
- Sector
- DAWN Health Care
- ULH Industrials
- Exchange
- DAWN Nasdaq
- ULH Nasdaq
- Market Cap
- DAWN 624.8M
- ULH 635.2M
- IPO Year
- DAWN 2021
- ULH 2005
- Fundamental
- Price
- DAWN $7.20
- ULH $27.14
- Analyst Decision
- DAWN Strong Buy
- ULH Hold
- Analyst Count
- DAWN 7
- ULH 1
- Target Price
- DAWN $27.86
- ULH $29.00
- AVG Volume (30 Days)
- DAWN 2.1M
- ULH 31.5K
- Earning Date
- DAWN 08-05-2025
- ULH 07-24-2025
- Dividend Yield
- DAWN N/A
- ULH 1.54%
- EPS Growth
- DAWN N/A
- ULH N/A
- EPS
- DAWN N/A
- ULH 2.31
- Revenue
- DAWN $187,638,000.00
- ULH $1,668,148,000.00
- Revenue This Year
- DAWN $16.42
- ULH N/A
- Revenue Next Year
- DAWN $47.52
- ULH $7.88
- P/E Ratio
- DAWN N/A
- ULH $11.77
- Revenue Growth
- DAWN 2190.50
- ULH N/A
- 52 Week Low
- DAWN $5.64
- ULH $20.60
- 52 Week High
- DAWN $16.76
- ULH $53.29
- Technical
- Relative Strength Index (RSI)
- DAWN 62.39
- ULH 59.51
- Support Level
- DAWN $6.71
- ULH $23.66
- Resistance Level
- DAWN $7.12
- ULH $25.52
- Average True Range (ATR)
- DAWN 0.32
- ULH 1.07
- MACD
- DAWN 0.10
- ULH 0.24
- Stochastic Oscillator
- DAWN 85.05
- ULH 98.67
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.